CHATTANOOGA, Tenn. – The American Cancer Society Cancer Action Network (ACS CAN) invites the community to join a Lights of Hope Night of Remembrance and Advocacy at Miller Park in downto
Earlier today, the American Cancer Society Cancer Action Network (ACS CAN) convened a coalition of cancer survivors, leading researchers, medical providers and community advocates to urge Pennsylvania’s Members of Congress to protect cancer research funding.
More than 100 organizations representing millions of patients with serious health conditions and health care professionals sent a letter to Congress expressing their strong support for the Clinical Trial Modernization Act. Introduced in the House of Representatives in May 2025 by Reps. Raul Ruiz (D-CA) and August Pfluger (R-FL), the bipartisan legislation would help remove cost and geographic barriers to patient participation in clinical trials.
Baton Rouge, LA. – Aug 12, 2025 – The American Cancer Society Cancer Action Network (ACS CAN) has placed two new billboards in Baton Rouge to catch Congress’s attention ahead of crucial votes coming up in Washington, D.C.
CHATTANOOGA, Tenn. – The American Cancer Society Cancer Action Network (ACS CAN) has placed five new billboards in the Chattanooga area to catch Congress’s attention ahead of crucial votes coming up in Washington, D.C.
Today, the U.S. Senate Committee on Appropriations considered and approved its draft FY26 appropriations bill that includes increases for the National Institutes of Health (NIH) and increases for federal cancer research funding at the National Cancer Institute (NCI).
BIRMINGHAM, Ala. – July 29, 2025 – The American Cancer Society Cancer Action Network (ACS CAN) has placed two new billboards in Alabama to catch Congress’s attention ahead of crucial votes coming up in Washington, D.C.
Un nuevo informe (en inglés) de la Oficina de Presupuesto del Congreso (CBO, por sus siglas en inglés), un organismo no partidista, concluye que los recortes propuestos a los Institutos Nacionales de la Salud (NIH) podrían reducir la cantidad de nuevos medicamentos que lleguen al mercado en las próximas tres décadas.